West Oak Capital Trimmed Its Southwest Airlines Co (LUV) Holding; Haemonetics (HAE) Has 1.11 Sentiment

Haemonetics Corporation (NYSE:HAE) Logo

West Oak Capital Llc decreased Southwest Airlines Co (LUV) stake by 20% reported in 2017Q4 SEC filing. West Oak Capital Llc sold 150 shares as Southwest Airlines Co (LUV)’s stock declined 14.07%. The West Oak Capital Llc holds 600 shares with $39.27 million value, down from 750 last quarter. Southwest Airlines Co now has $31.95B valuation. The stock decreased 0.33% or $0.18 during the last trading session, reaching $54.89. About 5.18 million shares traded or 0.50% up from the average. Southwest Airlines Co. (NYSE:LUV) has risen 7.20% since April 17, 2017 and is uptrending. It has underperformed by 4.35% the S&P500.

Haemonetics Corp (HAE) investors sentiment decreased to 1.11 in 2017 Q4. It’s down -0.17, from 1.28 in 2017Q3. The ratio is negative, as 108 institutional investors opened new and increased positions, while 97 decreased and sold their stakes in Haemonetics Corp. The institutional investors in our database now hold: 50.89 million shares, down from 52.55 million shares in 2017Q3. Also, the number of institutional investors holding Haemonetics Corp in top ten positions was flat from 1 to 1 for the same number . Sold All: 20 Reduced: 77 Increased: 60 New Position: 48.

Ratings analysis reveals 33% of Haemonetics’s analysts are positive. Out of 3 Wall Street analysts rating Haemonetics, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $34.0 while the high is $41.0. The stock’s average target of $37.50 is -49.83% below today’s ($74.75) share price. HAE was included in 3 notes of analysts from September 20, 2016. Barrington Research upgraded it to “Outperform” rating and $41.0 target in Tuesday, November 8 report. The firm has “Market Perform” rating given on Tuesday, September 20 by CJS Securities. As per Monday, November 7, the company rating was maintained by Benchmark.

The stock increased 1.95% or $1.43 during the last trading session, reaching $74.75. About 248,729 shares traded. Haemonetics Corporation (HAE) has risen 82.56% since April 17, 2017 and is uptrending. It has outperformed by 71.01% the S&P500.

Healthcor Management L.P. holds 2.74% of its portfolio in Haemonetics Corporation for 1.45 million shares. Rutabaga Capital Management Llc Ma owns 178,976 shares or 2.39% of their US portfolio. Moreover, Beaconlight Capital Llc has 1.97% invested in the company for 92,317 shares. The Quebec – Canada-based Van Berkom & Associates Inc. has invested 1.84% in the stock. Anchor Capital Advisors Llc, a Massachusetts-based fund reported 744,564 shares.

Analysts await Haemonetics Corporation (NYSE:HAE) to report earnings on May, 8 before the open. They expect $0.43 EPS, up 10.26% or $0.04 from last year’s $0.39 per share. HAE’s profit will be $22.98M for 43.46 P/E if the $0.43 EPS becomes a reality. After $0.62 actual EPS reported by Haemonetics Corporation for the previous quarter, Wall Street now forecasts -30.65% negative EPS growth.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company has market cap of $4.00 billion. The firm operates through five divisions: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It currently has negative earnings. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma clients to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection and processing products.

Since January 1, 0001, it had 0 buys, and 3 selling transactions for $484,765 activity.

Analysts await Southwest Airlines Co. (NYSE:LUV) to report earnings on April, 26 before the open. They expect $0.75 EPS, up 22.95% or $0.14 from last year’s $0.61 per share. LUV’s profit will be $436.50M for 18.30 P/E if the $0.75 EPS becomes a reality. After $0.77 actual EPS reported by Southwest Airlines Co. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

West Oak Capital Llc increased Constellation Brand Cl A (NYSE:STZ) stake by 125 shares to 475 valued at $108.57 million in 2017Q4. It also upped Avery Dennison Corp (NYSE:AVY) stake by 800 shares and now owns 1,500 shares. Irobot Corp (NASDAQ:IRBT) was raised too.

Among 20 analysts covering Southwest Airlines Co. (NYSE:LUV), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. Southwest Airlines Co. has $106 highest and $41 lowest target. $67.43’s average target is 22.85% above currents $54.89 stock price. Southwest Airlines Co. had 70 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, January 8 by Cowen & Co. Stephens maintained Southwest Airlines Co. (NYSE:LUV) on Monday, January 8 with “Buy” rating. The company was downgraded on Tuesday, January 30 by JP Morgan. On Monday, November 13 the stock rating was maintained by Morgan Stanley with “Overweight”. The firm earned “Strong-Buy” rating on Tuesday, August 18 by Vetr. The firm earned “Overweight” rating on Thursday, January 5 by Morgan Stanley. Deutsche Bank maintained Southwest Airlines Co. (NYSE:LUV) on Friday, October 23 with “Buy” rating. The rating was maintained by Morgan Stanley with “Overweight” on Monday, March 26. Credit Suisse maintained the stock with “Outperform” rating in Tuesday, April 12 report. On Tuesday, July 26 the stock rating was upgraded by Evercore to “Buy”.

Southwest Airlines Co. (NYSE:LUV) Institutional Positions Chart